Montag & Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28K Sell
368
-55
-13% -$3.92K ﹤0.01% 650
2025
Q4
$26.3K Buy
423
+320
+311% +$18.8K ﹤0.01% 669
2025
Q3
$6.09K Hold
103
﹤0.01% 804
2025
Q2
$6.05K Buy
103
+47
+84% +$2.66K ﹤0.01% 787
2025
Q1
$2.8K Buy
+56
New +$2.87K ﹤0.01% 874
2023
Q1
Sell
-19
Closed -$1.4K 950
2022
Q4
$1.4K Hold
19
﹤0.01% 885
2022
Q3
$2K Hold
19
﹤0.01% 815
2022
Q2
$2K Hold
19
﹤0.01% 771
2022
Q1
$2K Buy
+19
New +$1.57K ﹤0.01% 785
2021
Q1
Sell
-60
Closed -$3K 883
2020
Q4
$3K Buy
+60
New +$2.65K ﹤0.01% 758

Other funds holding NTR

Montag & Associates's NTR Position: Q1 2026 in Review

Montag & Associates reduced its Nutrien (NTR) stake by 13% in Q1 2026, selling an estimated $3.92K and leaving 368 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #650.

Montag & Associates first reported a position in NTR in Q4 2020 and has held it in 10 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Montag & Associates held 368 shares of Nutrien worth $28K as of Q1 2026.
  • Montag & Associates sold 55 Nutrien shares in Q1 2026, an estimated $3.92K.
  • Nutrien made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #650 holding.
  • Montag & Associates first reported a position in Nutrien in Q4 2020 and has held it in 10 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.